Jeff Yass’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Jeff Yass’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,767	Closed	-$241K	–	14104
2022 Q3	$241K	Buy	+23,767	New	+$240K	﹤0.01%	10371

Other funds holding PBAXU

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jeff Yass's PBAXU Position: Q4 2022 in Review

Jeff Yass sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q4 2022, closing a stake of 23,767 shares — an estimated $241K sold.

Jeff Yass first reported a position in PBAXU in Q3 2022 and held it in 1 quarter. The position peaked at $241K in Q3 2022. 3 funds tracked by Wall St. Rank hold PBAXU as of Q4 2022.

Jeff Yass reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
Jeff Yass sold 23,767 Phoenix Biotech Acquisition Corp. Unit shares in Q4 2022, an estimated $241K.
Jeff Yass first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q3 2022 and held it in 1 quarter.
Jeff Yass's Phoenix Biotech Acquisition Corp. Unit position peaked at $241K in Q3 2022.
3 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.